Titre :
  • An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
Auteur : Schöffski, Patrick ; Adkins, Douglas D. ; Blay, Jean Yves ; Gil, Thierry ; Elias, Anthony A.D. ; Rutkowski, Piotr ; Pennock, Gregory G.K. ; Youssoufian, Hagop H. ; Gelderblom, Hans ; Willey, R. R. ; Grebennik, Dmitri D.O.
Informations sur la publication : European journal of cancer, 49, 15, (page 3219-3228)
Statut de publication : Publié, 2013-10
Sujet CREF : Cancérologie
Mots-clés : Adipocytic sarcoma
Cixutumumab
Ewing family of tumours
Insulin-like growth factor receptor
Leiomyosarcoma
Rhabdomyosarcoma
Soft-tissue sarcoma
Synovial sarcoma
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2013.06.010
info:pii/S0959804913004851
info:pmid/23835252